Vijaya Diagnostic Centre Ltd. Share Price

Overview

Vijaya Diagnostic Centre Ltd. share price is currently ₹1,566.32, up by ₹84.16 (5.68%) from its previous closing price of ₹1,482.16. The share price has gained 12.85% over the past month and gained 49.04% over the past year. The stock's 52-week low and high are ₹831.02 and ₹1,572.13, respectively. Vijaya Diagnostic Centre Ltd. has a market capitalisation of ₹ 15,572.74 Cr. The share price was last updated on 20 Nov 2026, 11:22 AM IST.

Vijaya Diagnostic Centre Ltd.
Vijaya Diagnostic Centre Ltd.
VIJAYA
 ₹0.00
 ₹84.16
5.68%
Healthcare
 ₹0.00(%)1D

Updated: 20 Nov 2026, 11:22:21 am IST

Market Data

Open Price

 ₹1,481.78

Prev. Close

 ₹1,482.16
 ₹1,479.24

Day Low

 ₹1,567.14

Day High

 ₹831.02

52 Week Low

 ₹1,572.13

52 Week High

HealthcareHospital & Healthcare Services
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

79.11

Sector PE

45.96

PB Ratio

16.89

Sector PB

6.03

EPS

19.80

Dividend Yield

0.23

Today's Volume

266.187 K

5 Day Avg. Volume

365.047 K

PEG Ratio

3.96

Market Cap.

₹ 15,572.74 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 200% at ₹2/Share
16-Sep-202616-Sep-2026
DividendsFinal Dividend of 200% at ₹2/Share
29-Aug-202529-Aug-2025
DividendsFinal Dividend of 100% at ₹1/Share
30-Aug-202430-Aug-2024

Mutual Fund Ownership

Mutual Fund Holder
Sep 26
Shares held
Oct 26
Shares held
Kotak Small Cap Fund - Growth54.55 Lac
54.55 Lac
no change
HDFC Small Cap Fund - Regular Plan - Growth46.16 Lac
46.16 Lac
no change
Nippon India Multi Cap Fund - Growth29.14 Lac
31.30 Lac
(7.41%)
HSBC Small Cap Fund - Regular Plan - Growth25.04 Lac
25.04 Lac
no change
Axis Small Cap Fund - Regular Plan - Growth20.62 Lac
20.62 Lac
no change

About Vijaya Diagnostic Centre Ltd. 👋

Vijaya Diagnostic Centre Limited is an India-based company, which is engaged in the business of providing a range of diagnostic services, spanning pathological investigations, basic and high-end radiology, nuclear medicine, and related healthcare services. It operates through the Diagnostic Services segment. It offers laboratory services and radiology services. Its services include clinical pathology, microbiology, hematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, computerized tomography (CT) scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine, and MRI-3T. It operates approximately 160 diagnostic centers in 25 cities spread across India. Its clinical pathology includes liver function test (LFT-A), creatine kinase (CPK) test, and thyroid profile test. It offers various health checkups, which include general wellness, women's care, gynecology packages, and lifestyle.

Analyst Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
Aashish

Aashish

18 Nov • 6:44 PM · SEBI-Registered Analyst

VIJAYA DIAGNOSTIC CENTRE – SWOT ANALYSIS

VIJAYA Strengths - Strong brand in diagnostic healthcare. - Leading presence in South India. - Integrated pathology and radiology services. - High EBITDA margins of 44.1%. - Strong B2C business model (92% revenue). - Asset-light operating model in selected locations. - Strong cash generation and debt-free balance sheet. Weaknesses - High geographical concentration in South India. - Significant investment required for expansion. - High dependence on skilled medical professionals. - New diagnostic centres require time to break even. - High competition in routine diagnostic tests. Opportunities - Growing preventive healthcare demand. - Expansion into new cities and markets. - Growth in advanced pathology and radiology. - Increasing demand for preventive health packages. - Expansion through acquisitions. - Rising healthcare awareness in Tier-2 and Tier-3 cities. Threats - Competition from Dr Lal PathLabs and Metropolis. - Pricing pressure from local diagnostic centres. - Regulatory changes in healthcare. - Rising employee and equipment costs. - Technology changes and equipment obsolescence. - Aggressive expansion by organised diagnostic chains.

See More
Aalgo Breaths

Aalgo Breaths

7 Nov • 7:59 PM · SEBI-Registered Analyst

Vijaya Diagnostic Centre Ltd – Bullish Recovery

VIJAYA Vijaya Diagnostic Centre is showing encouraging signs of recovery following its recent correction. Fresh buying interest is gradually emerging, while momentum indicators are showing signs of improvement. The stock is now approaching an important resistance zone, making the upcoming price action crucial. 🔎 Technical View: • Strong recovery from recent support levels • Gradual improvement in buying interest • Momentum indicators showing positive signals 🔑 Key Levels to Watch: • Support: ₹1,459 – ₹1,418 • Major Support: ₹1,390 – ₹1,376 • Resistance: ₹1,491 – ₹1,501 🚀 Potential Upside Targets: • Target 1: ₹1,542 • Target 2: ₹1,584 • Target 3: ₹1,625+ 📈 Trading Perspective: A sustained breakout above ₹1,501 could strengthen the bullish recovery and open the possibility of further upside towards the mentioned target levels. However, a breakdown below ₹1,418 may weaken the recovery momentum and require caution. Traders should closely monitor price action around the resistance zone before considering any trading decision. Proper risk management remains essential. ⚠️ Disclaimer: Shared for educational and informational purposes only. This is not a buy/sell recommendation. — AALGO BREATHS 📊

See More
Mohammed Shoaib Dayma

Mohammed Shoaib Dayma

5 Nov • 12:04 PM · SEBI-Registered Analyst

VIJAYA DIAGNOSTIC: PROFIT INCREASES TO 37%

VIJAYA Centre reported a positive Q2 FY27 performance, with net profit increasing 37.2% year-on-year to approximately ₹59 crore. The company operates in the diagnostic-services industry, where growth is driven by testing volumes, new centres, specialised services and patient acquisition. Important factors to monitor: - Revenue and test-volume growth - New diagnostic centre performance - Average revenue per patient - Specialty testing contribution - Operating margins My view: Consistent demand for diagnostic services can support long-term business growth. The important factor is whether expansion is generating healthy returns rather than simply increasing the number of centres. Disclosure: This note represents my independent research assessment. I do not hold this stock. This is for informational purposes and should not be considered a recommendation to buy or sell.

See More
Saurab Jain

Saurab Jain

4 Nov • 12:59 PM · SEBI-Registered Analyst

Vijaya Diagnostic Q2 profit rises 37.4%, revenue up 26.7%

Vijaya Diagnostic Q2 profit rises 37.4% and revenue grows 26.7%. Shares turn volatile, with Rs 1,600 resistance and Rs 1,330 support in focus. Vijaya Diagnostic Centre Limited [ VIJAYA ] reported strong consolidated Q2 results for the September quarter, with net profit increasing 37.4% year on year to Rs 59.5 crore from Rs 43.3 crore. Revenue also grew 26.7% to Rs 255.4 crore compared with Rs 201.6 crore in the corresponding quarter last year. Despite the healthy quarterly performance, the stock witnessed significant volatility in today's trading session. Shares moved to a one-month high before facing selling pressure and trading in the red. The latest price action has also engulfed the entire trading range of the previous six sessions, indicating increased volatility following the quarterly results. From a technical perspective, Rs 1,600 is an important resistance zone, positioned just above the previous all-time high and near a psychological price level. On the downside, Rs 1,330 remains an important support in the near term. The broader technical structure remains sideways to bullish. A sustained move above the resistance zone could strengthen the upward momentum, while holding support remains crucial for maintaining the positive bias. Disclaimer: I do not hold any position in this stock. This is not a recommendation to buy or sell. Investments in securities markets are subject to market risks. Read all related documents carefully before investing.

See More
Akhilesh Jat

Akhilesh Jat

4 Nov • 12:07 PM · SEBI-Registered Analyst

Vijaya Diagnostic Centre Q2 profit rises 37.4% YoY

Vijaya Diagnostic Centre reported a 37.4% rise in Q2 profit and 26.7% revenue growth, while the daily chart shows price near a rising trendline. Vijaya Diagnostic Centre Limited [ VIJAYA ] reported Q2 consolidated profit of Rs 59.5 crore, up 37.4% from Rs 43.3 crore a year ago. Revenue rose 26.7% to Rs 255.4 crore from Rs 201.6 crore. The stock turned volatile today as the market reacted to the numbers. Profit grew faster than revenue, which may point to better cost control on a larger base. On the daily chart, price rose from the May low and respected a rising trendline for months. It slipped below the line in mid October, found a base near Rs 1,335 and moved back to the line in early November. Today’s candle has long shadows on both sides, with a high of Rs 1,505 and a low of Rs 1,381.4. Price is trading near Rs 1,425, which shows buyers and sellers are active around the trendline. What next: Rs 1,335 is the support. A fall below it may weaken the structure. Rs 1,593.6, the September high, is the resistance, and a close above it may bring a stronger move. Conclusion: The setup stays neutral until price closes clearly above resistance or below support. Disclaimer: I, Akhilesh Jat (SEBI RA Reg. No. INH000016649), do not hold any position in the stock discussed. This content is informational, not a recommendation. Investments in securities are subject to market risks. Read all related documents carefully before investing.

See More
Harika Enjamuri

Harika Enjamuri

4 Nov • 9:00 AM · SEBI-Registered Analyst

Vijaya Diagnostic reports 37% profit growth in Q2

Vijaya Diagnostic Centre Limited reported a 37.4% year-on-year increase in Q2 FY27 net profit to ₹59.5 crore, supported by strong revenue growth and improved operating margins. Revenue rose 26.7% to ₹255.4 crore, while EBITDA increased 37.8% to ₹112.7 crore. EBITDA margin expanded by 350 basis points to 44.1% from 40.6% a year ago. The company also reported 16.5% growth in test volumes, indicating that the performance was supported by higher business volumes as well as better operating efficiency. Existing centres recorded approximately 20% growth, while newer centres continued to contribute as they ramped up. The company has commissioned 2 hubs and 7 spokes in FY27 so far, with another 3 hubs and 7 spokes planned in the second half. Its proposed acquisition of Arya Wellness Centre in Guwahati also marks its entry into the North-East market. In my view, the most encouraging part of these results is the combination of volume growth and margin expansion. Revenue growth alone would be less convincing, but EBITDA growing faster than revenue suggests improved operating leverage. The expansion into new markets could support future growth, although new centres and acquisitions will need to deliver adequate volumes without putting pressure on margins. Going ahead, I will be tracking volume growth, the ramp-up of new centres and whether EBITDA margins remain above 40%. The company's ability to sustain this growth while managing expansion costs will be important. Vijaya Diagnostic closed at ₹1,443.95 on the BSE, down 0.95%. My view is positive on the operating performance, but I would watch execution and valuation before taking a fresh investment call. VIJAYA Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.

See More

News & Events

Frequently Asked Questions

What is the share price of Vijaya Diagnostic Centre Ltd.?

What is the market cap of Vijaya Diagnostic Centre Ltd.?

Should I buy Vijaya Diagnostic Centre Ltd. stock now?

What is the 52 week high and low of Vijaya Diagnostic Centre Ltd.?

Is the Vijaya Diagnostic Centre Ltd. stock good to buy?

Is Vijaya Diagnostic Centre Ltd. a good buy for the long term?

Is Vijaya Diagnostic Centre Ltd. overvalued or undervalued?

What is the PE and PB ratio of Vijaya Diagnostic Centre Ltd.?

Start Now